CD274 and non-small cell lung carcinoma: By contract, this study suggests that PEM plus PBC is a preferable strategy for the squamous NSCLC group regardless of PD‐L1 status, while the SITC recommended PEM alone for squamous patients with NSCLC with PD‐L1 ≥50%.